research Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
The study involving 1,226 participants examined the dermatologic effects of weight management treatments, particularly glucagon-like peptide 1-receptor agonists (GLP-1RAs). It found that greater weight loss was associated with increased reports of negative aesthetic impacts such as skin sagging, facial volume loss, and hair shedding. Specifically, among those losing more than 20% of body weight, 72% reported skin sagging and 52% reported hair loss. However, improvements were noted in preexisting inflammatory and hormonally driven skin conditions like hidradenitis suppurativa and acanthosis nigricans. The findings highlight the need for further research into the mechanisms and incidence of these outcomes with GLP-1RA treatments.
